While indisulam monotherapy has shown limited anti-tumor activity, albeit with acceptable toxicity [48], combining RBM39 degraders with MGMT inhibitors such as O6-BG could yield synergistic suppression of MGMT with reduced toxicity. Here, MGMT is linked to neoplasm.